Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alkermes, Inc.
David Anstice Elected to Alkermes' Board of Directors
October 24th, 2008
Alkermes, Inc. (NASDAQ: ALKS) announced the election of David Anstice to the company's Board of Directors. Mr. Anstice brings more than 30 years of experience serving in executive management positions and leading major global activities in the pharmaceutical industry. "We are very pleased to welcome David to our Board, as he has long-standing experience as a senior pharmaceutical executive with a unique perspective on growing biotech businesses," said Richard F. Pops, Chairman of the Board of Directors of Alkermes. "We look forward to his contributions as we work toward enhancing the company's business and accelerating its growth." During his career,...
Source: Health Business Week (2008-10-24)
|
